{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T12:09:11Z","timestamp":1792238951893,"version":"4.4.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T00:00:00Z","timestamp":1733270400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T00:00:00Z","timestamp":1733270400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2025,3,17]]},"DOI":"10.1038\/s41388-024-03237-4","type":"journal-article","created":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T15:48:22Z","timestamp":1733327302000},"page":"601-617","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Breast cancer stem cell-derived exosomal lnc-PDGFD induces fibroblast-niche formation and promotes lung metastasis"],"prefix":"10.1038","volume":"44","author":[{"given":"Tingting","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7535-3980","authenticated-orcid":false,"given":"Tao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijie","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dameng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenxi","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0208-6410","authenticated-orcid":false,"given":"Junnian","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9508-3104","authenticated-orcid":false,"given":"Liang","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0816-6630","authenticated-orcid":false,"given":"Bo","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,4]]},"reference":[{"key":"3237_CR1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clinicians. 2023;73:17\u201348.","journal-title":"CA Cancer J Clinicians"},{"key":"3237_CR2","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41571-021-00565-2","volume":"19","author":"G Bianchini","year":"2022","unstructured":"Bianchini G, De Angelis C, Licata L, Gianni L. Treatment landscape of triple-negative breast cancer - expanded options, evolving needs. Nat Rev Clin Oncol. 2022;19:91\u2013113.","journal-title":"Nat Rev Clin Oncol"},{"key":"3237_CR3","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.semcancer.2021.06.015","volume":"82","author":"Z Hua","year":"2022","unstructured":"Hua Z, White J, Zhou J. Cancer stem cells in TNBC. Semin Cancer Biol. 2022;82:26\u201334.","journal-title":"Semin Cancer Biol"},{"key":"3237_CR4","first-page":"321","volume":"4","author":"N Fultang","year":"2021","unstructured":"Fultang N, Chakraborty M, Peethambaran B. Regulation of cancer stem cells in triple negative breast cancer. Cancer Drug Resistance. 2021;4:321\u201342.","journal-title":"Cancer Drug Resistance"},{"key":"3237_CR5","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s13045-022-01341-0","volume":"15","author":"Y Li","year":"2022","unstructured":"Li Y, Zhang H, Merkher Y, Chen L, Liu N, Leonov S, et al. Recent advances in therapeutic strategies for triple-negative breast cancer. J Hematol Oncol. 2022;15:121.","journal-title":"J Hematol Oncol"},{"key":"3237_CR6","doi-asserted-by":"crossref","unstructured":"Park SY, Choi JH, Nam JS. Targeting Cancer Stem Cells in Triple-Negative Breast Cancer. Cancers. 2019;11:965.","DOI":"10.3390\/cancers11070965"},{"key":"3237_CR7","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216234","volume":"566","author":"G Dong","year":"2023","unstructured":"Dong G, Chen P, Xu Y, Liu T, Yin R. Cancer-associated fibroblasts: Key criminals of tumor pre-metastatic niche. Cancer Lett. 2023;566:216234.","journal-title":"Cancer Lett"},{"key":"3237_CR8","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/s41571-021-00546-5","volume":"18","author":"Y Chen","year":"2021","unstructured":"Chen Y, McAndrews KM, Kalluri R. Clinical and therapeutic relevance of cancer-associated fibroblasts. Nat Rev Clin Oncol. 2021;18:792\u2013804.","journal-title":"Nat Rev Clin Oncol"},{"key":"3237_CR9","volume":"11","author":"Q Ji","year":"2020","unstructured":"Ji Q, Zhou L, Sui H, Yang L, Wu X, Song Q, et al. Primary tumors release ITGBL1-rich extracellular vesicles to promote distal metastatic tumor growth through fibroblast-niche formation. Nat Commun. 2020;11:1211.","journal-title":"Nat Commun"},{"key":"3237_CR10","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/j.cell.2023.03.010","volume":"186","author":"R Kalluri","year":"2023","unstructured":"Kalluri R, McAndrews KM. The role of extracellular vesicles in cancer. Cell. 2023;186:1610\u201326.","journal-title":"Cell"},{"key":"3237_CR11","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1016\/j.cmet.2021.09.002","volume":"33","author":"SM Morrissey","year":"2021","unstructured":"Morrissey SM, Zhang F, Ding C, Montoya-Durango DE, Hu X, Yang C, et al. Tumor-derived exosomes drive immunosuppressive macrophages in a pre-metastatic niche through glycolytic dominant metabolic reprogramming. Cell Metab. 2021;33:2040\u201358.e2010.","journal-title":"Cell Metab"},{"key":"3237_CR12","volume":"18","author":"W Feng","year":"2019","unstructured":"Feng W, Dean DC, Hornicek FJ, Shi H, Duan Z. Exosomes promote pre-metastatic niche formation in ovarian cancer. Mol Cancer. 2019;18:124.","journal-title":"Mol Cancer"},{"key":"3237_CR13","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/ncb3169","volume":"17","author":"B Costa-Silva","year":"2015","unstructured":"Costa-Silva B, Aiello NM, Ocean AJ, Singh S, Zhang H, Thakur BK, et al. Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver. Nat Cell Biol. 2015;17:816\u201326.","journal-title":"Nat Cell Biol"},{"key":"3237_CR14","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/ncb3094","volume":"17","author":"MY Fong","year":"2015","unstructured":"Fong MY, Zhou W, Liu L, Alontaga AY, Chandra M, Ashby J, et al. Breast-cancer-secreted miR-122 reprograms glucose metabolism in premetastatic niche to promote metastasis. Nat Cell Biol. 2015;17:183\u201394.","journal-title":"Nat Cell Biol"},{"key":"3237_CR15","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.7150\/thno.45351","volume":"11","author":"X Yuan","year":"2021","unstructured":"Yuan X, Qian N, Ling S, Li Y, Sun W, Li J, et al. Breast cancer exosomes contribute to pre-metastatic niche formation and promote bone metastasis of tumor cells. Theranostics. 2021;11:1429\u201345.","journal-title":"Theranostics"},{"key":"3237_CR16","doi-asserted-by":"crossref","first-page":"13993","DOI":"10.3390\/ijms232213993","volume":"23","author":"S Huang","year":"2022","unstructured":"Huang S, Dong M, Chen Q. Tumor-Derived Exosomes and Their Role in Breast Cancer Metastasis. Int J Mol Sci. 2022;23:13993.","journal-title":"Int J Mol Sci"},{"key":"3237_CR17","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nature15756","volume":"527","author":"A Hoshino","year":"2015","unstructured":"Hoshino A, Costa-Silva B, Shen TL, Rodrigues G, Hashimoto A, Tesic Mark M, et al. Tumour exosome integrins determine organotropic metastasis. Nature. 2015;527:329\u201335.","journal-title":"Nature"},{"key":"3237_CR18","doi-asserted-by":"crossref","first-page":"5157","DOI":"10.1021\/pr8004887","volume":"7","author":"J Conde-Vancells","year":"2008","unstructured":"Conde-Vancells J, Rodriguez-Suarez E, Embade N, Gil D, Matthiesen R, Valle M, et al. Characterization and comprehensive proteome profiling of exosomes secreted by hepatocytes. J Proteome Res. 2008;7:5157\u201366.","journal-title":"J Proteome Res"},{"key":"3237_CR19","doi-asserted-by":"crossref","first-page":"876","DOI":"10.3390\/biomedicines9080876","volume":"9","author":"DD Singh","year":"2021","unstructured":"Singh DD, Yadav DK. TNBC: Potential Targeting of Multiple Receptors for a Therapeutic Breakthrough, Nanomedicine, and Immunotherapy. Biomedicines. 2021;9:876.","journal-title":"Biomedicines"},{"key":"3237_CR20","volume":"18","author":"Y Guo","year":"2019","unstructured":"Guo Y, Ji X, Liu J, Fan D, Zhou Q, Chen C, et al. Effects of exosomes on pre-metastatic niche formation in tumors. Mol Cancer. 2019;18:39.","journal-title":"Mol Cancer"},{"key":"3237_CR21","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2013.07.036","volume":"154","author":"XH Zhang","year":"2013","unstructured":"Zhang XH, Jin X, Malladi S, Zou Y, Wen YH, Brogi E, et al. Selection of bone metastasis seeds by mesenchymal signals in the primary tumor stroma. Cell. 2013;154:1060\u201373.","journal-title":"Cell"},{"key":"3237_CR22","volume":"17","author":"Z Sun","year":"2018","unstructured":"Sun Z, Yang S, Zhou Q, Wang G, Song J, Li Z, et al. Emerging role of exosome-derived long non-coding RNAs in tumor microenvironment. Mol Cancer. 2018;17:82.","journal-title":"Mol Cancer"},{"key":"3237_CR23","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S0962-8924(00)01802-X","volume":"10","author":"F Grinnell","year":"2000","unstructured":"Grinnell F. Fibroblast-collagen-matrix contraction: growth-factor signalling and mechanical loading. Trends Cell Biol. 2000;10:362\u20135.","journal-title":"Trends Cell Biol"},{"key":"3237_CR24","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1093\/bib\/bbv031","volume":"17","author":"F Ferr\u00e8","year":"2016","unstructured":"Ferr\u00e8 F, Colantoni A, Helmer-Citterich M. Revealing protein-lncRNA interaction. Brief Bioinforma. 2016;17:106\u201316.","journal-title":"Brief Bioinforma"},{"key":"3237_CR25","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2021.110073","volume":"85","author":"A Alkrekshi","year":"2021","unstructured":"Alkrekshi A, Wang W, Rana PS, Markovic V, Sossey-Alaoui K. A comprehensive review of the functions of YB-1 in cancer stemness, metastasis and drug resistance. Cell Signal. 2021;85:110073.","journal-title":"Cell Signal"},{"key":"3237_CR26","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/cr.2010.183","volume":"21","author":"G He","year":"2011","unstructured":"He G, Karin M. NF-\u03baB and STAT3 - key players in liver inflammation and cancer. Cell Res. 2011;21:159\u201368.","journal-title":"Cell Res"},{"key":"3237_CR27","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/cas.15609","volume":"114","author":"Y Yamamoto","year":"2023","unstructured":"Yamamoto Y, Kasashima H, Fukui Y, Tsujio G, Yashiro M, Maeda K. The heterogeneity of cancer-associated fibroblast subpopulations: Their origins, biomarkers, and roles in the tumor microenvironment. Cancer Sci. 2023;114:16\u201324.","journal-title":"Cancer Sci"},{"key":"3237_CR28","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.bbrc.2013.06.089","volume":"437","author":"N Erez","year":"2013","unstructured":"Erez N, Glanz S, Raz Y, Avivi C, Barshack I. Cancer associated fibroblasts express pro-inflammatory factors in human breast and ovarian tumors. Biochemical Biophys Res Commun. 2013;437:397\u2013402.","journal-title":"Biochemical Biophys Res Commun"},{"key":"3237_CR29","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-22450-3","volume":"12","author":"T Nishina","year":"2021","unstructured":"Nishina T, Deguchi Y, Ohshima D, Takeda W, Ohtsuka M, Shichino S, et al. Interleukin-11-expressing fibroblasts have a unique gene signature correlated with poor prognosis of colorectal cancer. Nat Commun. 2021;12:2281.","journal-title":"Nat Commun"},{"key":"3237_CR30","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2217\/imt.15.17","volume":"7","author":"TL Putoczki","year":"2015","unstructured":"Putoczki TL, Ernst M. IL-11 signaling as a therapeutic target for cancer. Immunotherapy. 2015;7:441\u201353.","journal-title":"Immunotherapy"},{"key":"3237_CR31","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature24676","volume":"552","author":"S Schafer","year":"2017","unstructured":"Schafer S, Viswanathan S, Widjaja AA, Lim WW, Moreno-Moral A, DeLaughter DM, et al. IL-11 is a crucial determinant of cardiovascular fibrosis. Nature. 2017;552:110\u20135.","journal-title":"Nature"},{"key":"3237_CR32","doi-asserted-by":"crossref","first-page":"eaau6977","DOI":"10.1126\/science.aau6977","volume":"367","author":"R Kalluri","year":"2020","unstructured":"Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020;367:eaau6977.","journal-title":"Science"},{"key":"3237_CR33","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.clon.2011.03.013","volume":"23","author":"EA Rakha","year":"2011","unstructured":"Rakha EA, Chan S. Metastatic triple-negative breast cancer. Clin Oncol. 2011;23:587\u2013600.","journal-title":"Clin Oncol"},{"key":"3237_CR34","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/nrc.2017.6","volume":"17","author":"H Peinado","year":"2017","unstructured":"Peinado H, Zhang H, Matei IR, Costa-Silva B, Hoshino A, Rodrigues G, et al. Pre-metastatic niches: organ-specific homes for metastases. Nat Rev Cancer. 2017;17:302\u201317.","journal-title":"Nat Rev Cancer"},{"key":"3237_CR35","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.ccell.2016.09.011","volume":"30","author":"Y Liu","year":"2016","unstructured":"Liu Y, Cao X. Characteristics and Significance of the Pre-metastatic Niche. Cancer Cell. 2016;30:668\u201381.","journal-title":"Cancer Cell"},{"key":"3237_CR36","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/nrc.2016.73","volume":"16","author":"R Kalluri","year":"2016","unstructured":"Kalluri R. The biology and function of fibroblasts in cancer. Nat Rev Cancer. 2016;16:582\u201398.","journal-title":"Nat Rev Cancer"},{"key":"3237_CR37","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jhep.2018.12.004","volume":"70","author":"M Cadamuro","year":"2019","unstructured":"Cadamuro M, Brivio S, Mertens J, Vismara M, Moncsek A, Milani C, et al. Platelet-derived growth factor-D enables liver myofibroblasts to promote tumor lymphangiogenesis in cholangiocarcinoma. J Hepatol. 2019;70:700\u20139.","journal-title":"J Hepatol"},{"key":"3237_CR38","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1002\/hep.26384","volume":"58","author":"M Cadamuro","year":"2013","unstructured":"Cadamuro M, Nardo G, Indraccolo S, Dall\u2019olmo L, Sambado L, Moserle L, et al. Platelet-derived growth factor-D and Rho GTPases regulate recruitment of cancer-associated fibroblasts in cholangiocarcinoma. Hepatology. 2013;58:1042\u201353.","journal-title":"Hepatology"},{"key":"3237_CR39","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12186","volume":"11","author":"S Zhao","year":"2022","unstructured":"Zhao S, Mi Y, Zheng B, Wei P, Gu Y, Zhang Z, et al. Highly-metastatic colorectal cancer cell released miR-181a-5p-rich extracellular vesicles promote liver metastasis by activating hepatic stellate cells and remodelling the tumour microenvironment. J Extracell Vesicles. 2022;11:e12186.","journal-title":"J Extracell Vesicles"},{"key":"3237_CR40","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/s41419-022-04506-4","volume":"13","author":"C Zhang","year":"2022","unstructured":"Zhang C, Wang XY, Zhang P, He TC, Han JH, Zhang R, et al. Cancer-derived exosomal HSPC111 promotes colorectal cancer liver metastasis by reprogramming lipid metabolism in cancer-associated fibroblasts. Cell Death Dis. 2022;13:57.","journal-title":"Cell Death Dis"},{"key":"3237_CR41","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/s41556-018-0083-6","volume":"20","author":"W Yan","year":"2018","unstructured":"Yan W, Wu X, Zhou W, Fong MY, Cao M, Liu J, et al. Cancer-cell-secreted exosomal miR-105 promotes tumour growth through the MYC-dependent metabolic reprogramming of stromal cells. Nat Cell Biol. 2018;20:597\u2013609.","journal-title":"Nat Cell Biol"},{"key":"3237_CR42","volume":"548","author":"Z He","year":"2022","unstructured":"He Z, Wang J, Zhu C, Xu J, Chen P, Jiang X, et al. Exosome-derived FGD5-AS1 promotes tumor-associated macrophage M2 polarization-mediated pancreatic cancer cell proliferation and metastasis. Cancer Lett. 2022;548:215751.","journal-title":"Cancer Lett"},{"key":"3237_CR43","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41392-020-0129-7","volume":"5","author":"C Ni","year":"2020","unstructured":"Ni C, Fang QQ, Chen WZ, Jiang JX, Jiang Z, Ye J, et al. Breast cancer-derived exosomes transmit lncRNA SNHG16 to induce CD73+\u03b3\u03b41 Treg cells. Signal Transduct Target Ther. 2020;5:41.","journal-title":"Signal Transduct Target Ther"},{"key":"3237_CR44","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/wrna.1200","volume":"5","author":"DN Lyabin","year":"2014","unstructured":"Lyabin DN, Eliseeva IA, Ovchinnikov LP. YB-1 protein: functions and regulation. Wiley Interdiscip Rev RNA. 2014;5:95\u2013110.","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"3237_CR45","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s41419-022-04723-x","volume":"13","author":"H Su","year":"2022","unstructured":"Su H, Fan G, Huang J, Qiu X. LncRNA HOXC-AS3 promotes non-small-cell lung cancer growth and metastasis through upregulation of YBX1. Cell Death Dis. 2022;13:307.","journal-title":"Cell Death Dis"},{"key":"3237_CR46","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1186\/s13046-022-02452-9","volume":"41","author":"Y Wang","year":"2022","unstructured":"Wang Y, Feng YC, Gan Y, Teng L, Wang L, La T, et al. LncRNA MILIP links YBX1 to translational activation of Snai1 and promotes metastasis in clear cell renal cell carcinoma. J Exp Clin Cancer Res CR. 2022;41:260.","journal-title":"J Exp Clin Cancer Res CR"},{"key":"3237_CR47","doi-asserted-by":"crossref","first-page":"10823","DOI":"10.7150\/thno.47830","volume":"10","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Huang YX, Wang DL, Yang B, Yan HY, Lin LH, et al. LncRNA DSCAM-AS1 interacts with YBX1 to promote cancer progression by forming a positive feedback loop that activates FOXA1 transcription network. Theranostics. 2020;10:10823\u201337.","journal-title":"Theranostics"},{"key":"3237_CR48","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.1074\/jbc.M116.740258","volume":"292","author":"M Martin","year":"2017","unstructured":"Martin M, Hua L, Wang B, Wei H, Prabhu L, Hartley AV, et al. Novel Serine 176 Phosphorylation of YBX1 Activates NF-\u03baB in Colon Cancer. J Biol Chem. 2017;292:3433\u201344.","journal-title":"J Biol Chem"},{"key":"3237_CR49","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/s41392-021-00641-0","volume":"6","author":"F Wu","year":"2021","unstructured":"Wu F, Yang J, Liu J, Wang Y, Mu J, Zeng Q, et al. Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancer. Signal Transduct Target Ther. 2021;6:218.","journal-title":"Signal Transduct Target Ther"},{"key":"3237_CR50","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/cac2.12291","volume":"42","author":"D Hu","year":"2022","unstructured":"Hu D, Li Z, Zheng B, Lin X, Pan Y, Gong P, et al. Cancer-associated fibroblasts in breast cancer: Challenges and opportunities. Cancer Commun. 2022;42:401\u201334.","journal-title":"Cancer Commun"},{"key":"3237_CR51","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.yexcr.2018.04.028","volume":"368","author":"X Wang","year":"2018","unstructured":"Wang X, Che X, Liu C, Fan Y, Bai M, Hou K, et al. Cancer-associated fibroblasts-stimulated interleukin-11 promotes metastasis of gastric cancer cells mediated by upregulation of MUC1. Exp Cell Res. 2018;368:184\u201393.","journal-title":"Exp Cell Res"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-024-03237-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-024-03237-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-024-03237-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T10:03:11Z","timestamp":1740391391000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-024-03237-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,4]]},"references-count":51,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,3,17]]}},"alternative-id":["3237"],"URL":"https:\/\/doi.org\/10.1038\/s41388-024-03237-4","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,4]]},"assertion":[{"value":"22 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Animal experiments were approved by the Ethics Committee of Xuzhou Medical University (No. 202209S095). An informed consent form was signed by all patients in accordance with the Declaration of Helsinki, and the study was approved by the Affiliated Hospital of Xuzhou Medical University (No. XYFY2021-KL038-01).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}